New promising molecular targets in head and neck squamous cell carcinoma

被引:34
作者
Bauman, Julie E. [2 ]
Michel, Loren S. [3 ,4 ]
Chung, Christine H. [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA
[2] Univ New Mexico, Ctr Canc, Dept Internal Med, Div Hematol Oncol, Albuquerque, NM 87131 USA
[3] Washington Univ, Sch Med, Dept Internal Med, Div Oncol,Dept Cell Biol & Physiol, St Louis, MO 63110 USA
[4] Washington Univ, Sch Med, Alvin J Siteman Canc Ctr, St Louis, MO USA
关键词
DNA damage repair; EGFR; HNSCC; HPV; hypoxia; MET; NOTCH; 1; PIK3CA; TP53; MESENCHYMAL-LIKE SUBPOPULATIONS; FACTOR RECEPTOR GENE; HUMAN-PAPILLOMAVIRUS; C-MET; TUMOR-SUPPRESSOR; HYPOXIC MODIFICATION; ACQUIRED-RESISTANCE; THERAPEUTIC TARGET; CANCER INCIDENCE; PLUS CETUXIMAB;
D O I
10.1097/CCO.0b013e3283517920
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Purpose of review Despite advances in multimodality therapy, the overall 5-year survival rate is 40-50% in patients with head and neck squamous cell carcinoma (HNSCC) and current multimodality approaches impart significant toxicities. This review highlights promising targets with the potential to improve clinical outcomes in HNSCC. Recent findings In addition to mutagenic exposure to tobacco and alcohol as risk factors, recent studies have shown that human papillomavirus is one of the main causes of HNSCC and as such is being investigated as a therapeutic target. Furthermore, recent data generated from whole exome sequencing of HNSCC, new insights into the biology of DNA damage repair, and increased understanding of tumor hypoxia responses are pointing to new therapeutic possibilities for treating HNSCC. Summary HNSCC is a heterogeneous disease. Improved treatment will require a rapid translation of basic science research, and the simultaneous development of novel therapeutics and corresponding biomarkers to guide their application.
引用
收藏
页码:235 / 242
页数:8
相关论文
共 93 条
[1]
Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in NOTCH1 [J].
Agrawal, Nishant ;
Frederick, Mitchell J. ;
Pickering, Curtis R. ;
Bettegowda, Chetan ;
Chang, Kyle ;
Li, Ryan J. ;
Fakhry, Carole ;
Xie, Tong-Xin ;
Zhang, Jiexin ;
Wang, Jing ;
Zhang, Nianxiang ;
El-Naggar, Adel K. ;
Jasser, Samar A. ;
Weinstein, John N. ;
Trevino, Lisa ;
Drummond, Jennifer A. ;
Muzny, Donna M. ;
Wu, Yuanqing ;
Wood, Laura D. ;
Hruban, Ralph H. ;
Westra, William H. ;
Koch, Wayne M. ;
Califano, Joseph A. ;
Gibbs, Richard A. ;
Sidransky, David ;
Vogelstein, Bert ;
Velculescu, Victor E. ;
Papadopoulos, Nickolas ;
Wheeler, David A. ;
Kinzler, Kenneth W. ;
Myers, Jeffrey N. .
SCIENCE, 2011, 333 (6046) :1154-1157
[2]
The ERCC1/XPF endonuclease is required for completion of homologous recombination at DNA replication forks stalled by inter-strand cross-links [J].
Al-Minawi, Ali Z. ;
Lee, Yin-Fai ;
Hakansson, Daniel ;
Johansson, Fredrik ;
Lundin, Cecilia ;
Saleh-Gohari, Nasrollah ;
Schultz, Niklas ;
Jenssen, Dag ;
Bryant, Helen E. ;
Meuth, Mark ;
Hinz, John M. ;
Helleday, Thomas .
NUCLEIC ACIDS RESEARCH, 2009, 37 (19) :6400-6413
[3]
Stressing the Ubiquitin-Proteasome System without 20S Proteolytic Inhibition Selectively Kills Cervical Cancer Cells [J].
Anchoori, Ravi K. ;
Khan, Saeed R. ;
Sueblinvong, Thanasak ;
Felthauser, Alicia ;
Iizuka, Yoshie ;
Gavioli, Riccardo ;
Destro, Federica ;
Vogel, Rachel Isaksson ;
Peng, Shiwen ;
Roden, Richard B. S. ;
Bazzaro, Martina .
PLOS ONE, 2011, 6 (08)
[4]
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer [J].
Ang, K. Kian ;
Harris, Jonathan ;
Wheeler, Richard ;
Weber, Randal ;
Rosenthal, David I. ;
Nguyen-Tan, Phuc Felix ;
Westra, William H. ;
Chung, Christine H. ;
Jordan, Richard C. ;
Lu, Charles ;
Kim, Harold ;
Axelrod, Rita ;
Silverman, C. Craig ;
Redmond, Kevin P. ;
Gillison, Maura L. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (01) :24-35
[5]
Early Tumor Progression Associated with Enhanced EGFR Signaling with Bortezomib, Cetuximab, and Radiotherapy for Head and Neck Cancer [J].
Argiris, Athanassios ;
Duffy, Austin G. ;
Kummar, Shivaani ;
Simone, Nicole L. ;
Arai, Yoshio ;
Kim, Seungwon W. ;
Rudy, Susan F. ;
Kannabiran, Vishnu R. ;
Yang, Xinping ;
Jang, Minyoung ;
Chen, Zhong ;
Suksta, Nanette ;
Cooley-Zgela, Theresa ;
Ramanand, Susmita G. ;
Ahsan, Aarif ;
Nyati, Mukesh K. ;
Wright, John J. ;
Van Waes, Carter .
CLINICAL CANCER RESEARCH, 2011, 17 (17) :5755-5764
[6]
ErbB-targeted therapeutic approaches in human cancer [J].
Arteaga, CL .
EXPERIMENTAL CELL RESEARCH, 2003, 284 (01) :122-130
[7]
Identification of inhibitors to papillomavirus type 16 E6 protein based on three-dimensional structures of interacting proteins [J].
Baleja, James D. ;
Cherry, Jonathan J. ;
Liu, Zhiguo ;
Gao, Hua ;
Nicklaus, Marc C. ;
Voigt, Johannes H. ;
Chen, Jason J. ;
Androphy, Elliot J. .
ANTIVIRAL RESEARCH, 2006, 72 (01) :49-59
[8]
Evidence for mesenchymal-like sub-populations within squamous cell carcinomas possessing chemoresistance and phenotypic plasticity [J].
Basu, D. ;
Nguyen, T-T K. ;
Montone, K. T. ;
Zhang, G. ;
Wang, L-P ;
Diehl, J. A. ;
Rustgi, A. K. ;
Lee, J. T. ;
Weinstein, G. S. ;
Herlyn, M. .
ONCOGENE, 2010, 29 (29) :4170-4182
[9]
Detecting and targeting mesenchymal-like subpopulations within squamous cell carcinomas [J].
Basu, Devraj ;
Montone, Kathleen T. ;
Wang, Li-Ping ;
Gimotty, Phyllis A. ;
Hammond, Rachel ;
Diehl, J. Alan ;
Rustgi, Anil K. ;
Lee, John T. ;
Rasanen, Kati ;
Weinstein, Gregory S. ;
Herlyn, Meenhard .
CELL CYCLE, 2011, 10 (12) :2008-2016
[10]
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck [J].
Bonner, JA ;
Harari, PM ;
Giralt, J ;
Azarnia, N ;
Shin, DM ;
Cohen, RB ;
Jones, CU ;
Sur, R ;
Raben, D ;
Jassem, J ;
Ove, R ;
Kies, MS ;
Baselga, J ;
Youssoufian, H ;
Amellal, N ;
Rowinsky, EK ;
Ang, KK .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (06) :567-578